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Mono- and multifunctional specific CD4+ and CD8+ T-cell responses were evaluated to improve the immune-based detection
of active tuberculosis (TB) and latent infection (LTBI). We applied flow cytometry to investigate cytokines profile (IFN-훾, TNF-훼, and IL-2) of T cells after stimulation with TB antigens in 28 TB-infected subjects (18 active TB and 10 LTBI) and 10 uninfected
controls. Cytokines production byCD4+ T cells at single-cell levels was higher in TB-infected subjects than uninfected controls (푃 <0.0001). Assigning to activated CD4+ T cells, producing any of the three cytokines, a cut-off >0.45%, it was possible to differentiate
TB-infected (>0.45%) by uninfected subjects (<0.45%). Among TB-infected subjects, the frequencies of multifunctional CD4+ T
cells, simultaneously producing all 3 cytokines, are lower in active TB than LTBI subjects (푃 = 0.003). Thus, assigning to triple-
positive CD4+ T cells a cut-off <0.182%, TB-infected individuals could be classified as active TB subjects (<0.182%) or LTBI subjects
(>0.182%). The magnitude of CD8+ T-cell responses showed no differences between active TB and LTBI. Multifunctional CD4+
T-cell responses could have the potential to identify at single time point subjects without TB infection and patients having active
or latent TB.
1. Introduction
Mycobacterium tuberculosis (Mtb) infects more than 2 billion
people worldwide; 90% of Mtb-infected individuals are able
to resist overt tuberculosis (TB) disease determining the
state of latency of infection (LTBI) [1]. Although latent and
active TB disease are likely part of a dynamic spectrum
[2, 3], individuals with LTBI are classically considered to be
asymptomatic and not infectious; thus, the accurate classifi-
cation of TB status is essential since treatment and prevention
approaches are entirely different.
All existing tests for LTBI diagnosis, the tuberculin skin
test (TST) and the newer interferon-gamma release assays
(IGRAs), are acceptable but remain imperfect tests [4].They
represent indirect markers of Mtb exposure and provide
immunological evidence of host sensitization to TB antigens.
Both tests depend on cell-mediated immunity, and neither
test can accurately differentiate between active TB and LTBI,
distinguish reactivation from reinfection, or discriminate the
various stages within the spectrum of Mtb infection [5, 6].
Thus, there is a need for newer biomarkers to classify patients
at a single time point as having active TB, LTBI, or no
infection.
Alternative immunological methods have been investi-
gated in recent years [7–11]. In particular, multifunctional
T cells, defined by their ability to coexpress two or more
cytokines, have showed a better diagnostic yield than IGRA
to detect TB infection [12–14] and have improved discrimi-
nation between active TB and LTBI [7–11, 15].
However, currently there is no consensus whether multi-
functional T cells represent a marker of protective immunity
or disease activity. Studies in animalmodels revealed a poten-
tial association of multifunctional Th1 cells with protective
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immunity to TB [16], but some recent studies in humans have
implicated multifunctional Th1 cells in protective immunity
against pulmonary disease [10, 17], while others have shown
that these cells might merely reflect the presence of active
disease [7, 9].
In the present study, we applied an intracellular cytokine
flow cytometry (ICCFC) to investigate monofunctional and
multifunctional Mtb-specific CD4+ and CD8+ T cells in
active TB and LTBI adults. Based on our findings, we
propose an immune-based approach, which could improve
the identification at single time point of subjects with no TB
infection or patients having active or latent TB.
2. Materials and Methods
2.1. Study Subjects. The study population included 38 subjects
enrolled at the Department of Public Health and Infectious
Diseases, “Sapienza” University, Rome, Italy. The subjects
were firstly classified into 2 main groups: TB infected and
uninfected subjects. TB infected people were subsequently
classified as active TB and latent TB. In summary, 18 patients
with active TB (age range, 26–61 years); 10 patients with LTBI
(age range, 41–60 years); and 10 healthy subjects (age range,
27–43 years) were recruited.
Diagnosis of active TB was made on the basis of clinical
and radiological findings andwas confirmed by identification
of M. tuberculosis with microbiological methods and/or
histological examination of affected tissues. All patients
presented tubercular lung involvement.
We classified as LTBI the subjects who tested positive for
both TST and QFT-GIT. All subjects classified as LTBI had
also one of the following risk factors: chest X-ray suggestive
of prior TB infection (apical pleural thickening, pulmonary
nodules, upper lobe bronchiectasis, interstitial granuloma-
tous calcification, cavitation, and lymph node or pericardial
calcification) and a history of exposure to a case of active
TB, originating from an area with a high prevalence of TB
infection.None of the individuals had clinical, radiologic, and
microbiological evidence of active TB, and none had received
prior TB treatment. The healthy subjects were unexposed
individuals with no previous history of TB, no know TB
contact and tested negative for TST and QFT-GIT.
Measurement of IFN-훾 levels by IGRA and multifunc-
tional analysis of CD4+ and CD8+ T cells were performed on
the same blood samples collected from all patients.
The study received approval from the Local Ethics Com-
mittee (reference number 2669), and informed consent was
provided by all subjects.
2.2. Tuberculin Skin Test and QuantiFERON TB Gold-In
Tube (QFT-GIT). After blood was drawn for the QFT-GIT
assay, a TST (Biocine Test PPD, Chiron, Siena, Italy) was
performed according to the Mantoux method by the same
experienced operator, considering an induration of ≥10mm
as positive.The QFT-GIT assay (Cellestis Limited, Carnegie,
Australia) was carried out and interpreted by the same
trained technician, as per the manufacturer’s instructions.
Both operators were blind to the clinical status of the patients.
2.3. Intracellular Cytokine Flow Cytometry (ICCFC). For
intracellular cytokine flow cytometry, heparinized peripheral
blood was collected, and 0.5mL of whole blood was added
to 3 test tubes containing, respectively, saline (negative con-
trol), phytohaemagglutinin (PHA), andTB antigens (ESAT-6,
CFP-10, and TB 7.7) [18].The test tubes were suppliedwith the
QFT-GIT.The TB antigens are pools of overlapping peptides
and are pooled together as a single stimulation condition.
Whole blood was costimulated with anti-CD28 plus anti-
CD49d (5 휇L/mL, BD Bioscience, Pharmingen, Italy) as indi-
cated by several authors [9, 10, 19], andBrefeldinA (10 휇g/mL)
(Sigma-Aldrich) was immediately added to each tube as
previously described [20]. In order to avoid aspecific stimu-
lation related to CD28/CD49d costimulation, we added anti-
CD28/CD49d antibodies to both negative (saline) and pos-
itive (PHA) control tubes and to TB antigens tubes (ESAT-
6, CFP-10, and TB 7.7) and we further subtracted the back-
ground values (in terms of IL-2, IFN-훾, and TNF-훼) from TB
antigens tubes.
In brief, after 18 hrs of incubation, the cell surface stain-
ing was performed with the following markers, anti-CD45-
VioBlue, anti-CD4 PE-Vio770, and anti-CD8 PerCP (Mil-
tenyi Biotec, Germany), and the red cells were lysed with
1mL FACS lysing solution (BD Bioscience). Cells were then
permeabilized with 0.5mL FACS permeabilizing solution
(BD Bioscience) and intracellularly stained with anti-IFN-훾
FITC, anti-TNF-훼 APC, and anti-IL-2 PE (Miltenyi Biotec).
Cells were fixed in 1%paraformaldehyde and analysed within
1 hr using a MACSQuant Analyzer flow cytometer (Miltenyi
Biotec) after calibration and automatic compensation. We
acquired at least 100,000 cells in the lymphocyte gate. FlowJo
Software version 7.6.5 was used to perform a “combination
gates” analysis. Seven different population cells were detected
in CD4+ and in CD8+ cell gate on the basis of IFN-훾, IL-2,
and TNF-훼 produced by CD4+ and CD8+ T cells (Figure 1).
Background cytokine production in negative control (saline
buffer) was subtracted from each stimulated condition. Intra-
assay coefficient of variation and interassay coefficient varia-
tion were estimated and were <5% and <10%, respectively.
We classed T cells producing any of the 3 cytokines (IFN-훾 or IL-2 or TNF-훼) as “activated T cells,” those producing
IFN-훾 alone or in combination with IL-2 and/or TNF-훼 as
“total IFN-훾+ T cells,” those producing IL-2 alone or in com-
bination with IFN-훾 and/or TNF-훼 as “total IL-2+ T cells,”
and those producing TNF-훼 alone or in combinationwith IL-
2 and/or IFN-훾 as “total TNF-훼+ T cells.” Similarly, we classed
polyfunctional T cells (those simultaneously producing all 3
cytokines) as “IFN-훾+ IL-2+ TNF-훼+ T cells.”
2.4. Statistical Analysis. GraphPad Prism Software version
5 (Software MacKiev) was used. Nonparametric Kruskal-
Wallis ANOVA with Dunn’s posttest comparison and non-
parametric Mann-Whitney test was applied to compare T-
cell frequencies and the percentage of cytokine-secreting cells
between 3 or 2 groups of patients, respectively. Receiver
operating characteristic (ROC) analysis was performed to
calculate optimal cut-off values for both activated CD4+ T
cells and polyfunctional CD4+ T cells. ROC curves were
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Figure 1: Representativeflow cytometry “combination gates” analysis ofCD4+ Tcells of LTBI, activeTB, and control subject under stimulation
of TB antigens. Whole blood was analysed using a gating strategy to exclude debris and to identify CD4+ and CD8+ T cells on CD45+
lymphocytes.The subsequent analysis was on CD4+ gate to describe IFN-훾, IL-2, and TNF-훼 producing T cells.The percentages of the seven
different population cells were showed at bottom and were defined in CD4+ cell gate on the basis of total IFN-훾, IL-2, and TNF-훼 producing
cells.
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Figure 2: Analysis of cytokine production by CD4+ cells at the single-cell level. (a) ROC curve (plotting sensitivity versus 1 − specificity)
to discriminate infected (active TB and LTBI) from uninfected patients. The area under curve (AUC) was 0.9722. (b) Analysis of activated
M. tuberculosis-specific CD4+T cells producing any of the 3 cytokines (IFN-훾, IL-2, or TNF-훼), using a cut-off to score responses as either
positive or negative.The subjects were considered as positive (black) whether the frequency of CD4+ T cells was >0.45% and negative (white)
when the frequency was <0.45%. Horizontal bars represent the median values and horizontal dashed line indicates the cut-off of 0.45%. ((c),
(d), and (e)) Frequency of “total IFN-훾+,” “total IL-2+,” and “total TNF-훼+”Mtb-specific CD4+T cells in active TB patients (푛 = 18), in LTBI
patients (푛 = 10), and in healthy controls (푛 = 10) is shown. Horizontal bars represent the median values. Statistical analysis was performed
using Kruskal-Wallis ANOVA with Dunn’s posttest comparison and significant differences are indicated by asterisks (∗∗푃 < 0.01).
generated by plotting the sensitivity against 1 − specificity,
and the area under the curve (AUC) with 95% confidence
intervals (95% CIs) was calculated. All statistical analyses
were two-sided and considered significant at 푃 values < 0.05.
3. Results
3.1. TST andQFT-GITResults. QFT-GITwas positive in 13/18
(72%), negative in 3/18 (17%), and indeterminate in 2/18 (11%)
of active TB patients. As expected, QFT-GIF was positive
in all 10 (100%) LTBI patients and in none of the healthy
controls.The TST was positive in all LTBI and negative in all
healthy controls, whereas it was positive in 11/18 (61%) and
7/18 (39%) of active TB patients.
3.2. Cytokine Flow Cytometry Analysis of Mtb-Specific CD4+ T
Cells at the Single-Cell Level. The expression of CD4+ T cells
producing any of the 3 cytokines (IFN-훾 or IL-2 or TNF-훼)
was assessed in patients with active TB, LTBI, and healthy
controls, after simulation with Mtb-specific antigens. A sig-
nificantly higher frequency of these CD4+ T cells was found
in active TB patients (median 1.197%, range 0.219%–3.59%)
and in LTBI patients (1.666%, 0.234–5.762%) if compared to
healthy controls (0.246%, 0–0.423%; 푃 < 0.0001 by Kruskal-
Wallis test); on the other hand, no significant differences were
found between the 2 infected group subjects. Following this
observation, we performed a ROC analysis (Figure 2(a)) and
a cut-off >0.45% for activated CD4+ T cells was found as the
value allowing the best combination of sensitivity (94.44%,
95% CI: 72.2–99.8%) and specificity (100%, 95% CI: 69.15–
100%; AUC 0.9722; 95% CI: 0.9141–1.030%, 푃 < 0.0001) to
differentiateMtb-infected patients (active TB and LTBI) from
healthy controls. Using this cut-off, we scored as positive 17/18
(95%) of active TB patients, 9/10 (90%) of LTBI patients, and
none of 10 healthy controls (Figure 2(b)). Thus, the analysis
of Mtb-specific CD4+ T cells allowed the discrimination
betweenMtb-infected and uninfected patients.
In another set of analyses, we compared the frequency
of “total IFN-훾+ CD4+ T cells,” “total IL-2+ CD4+ T cells,”
and “total TNF-훼+ CD4+ T cells” (as defined in Section 2)
in our 3 groups of the subjects. The frequencies of “total
IFN-훾+ CD4+ T cells” and “total IL-2+ CD4+ T cells”
were higher in LTBI patients compared to those with
active TB and healthy controls, although these differences
attained statistical significance only between Mtb-infected
(active TB and LTBI) and healthy subjects (푃 = 0.0014
for IFN-훾; 푃 = 0.0001 for IL-2 by Kruskal-Wallis test)
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Figure 3: Multifunctional cytokine analysis ofM. tuberculosis-specific CD4+ T cells. (a) Frequency ofMtb-specific CD4+ T cells producing all
combinations of IFN-훾, IL-2, and TNF-훼 in active TB patients (푛 = 18, black circles) and in LTBI patients (푛 = 10, white circles). Horizontal
bars represent the median values. Statistical analysis was performed using Mann-Whitney test and significant differences are indicated by
asterisks (∗∗푃 < 0.01, ∗푃 < 0.05). (b) Pie charts represent the relative proportions of cytokine-producing T-cell subsets in each group after
Mtb-specific stimulation. A key to colours used in the pie charts is shown at the bottom of the panel (a).
(Figures 2(c) and 2(d)). The frequency of “TNF-훼+ CD4+
T cells” was higher in patients with active and latent TB
than in healthy controls (푃 = 0.0003 by Kruskal-Wallis test;
Figure 2(e)).
Thus, the analysis of cytokine production byMtb-specific
CD4+ T cells at the single-cell level was unable to indicate TB
status among the studied subjects not allowing a distinction
between active TB and LTBI.
3.3. Multifunctional Cytokine Analysis of Mtb-Specific CD4+ T
Cells. We analysed our samples for all possible combinations
of intracellular expression of IFN-훾, IL-2, and TNF-훼 in
cytokine-producing CD4+ T cells in subjects with active and
latent TB. Significantly greater frequencies of both “IFN-훾+
TNF-훼+” and “IFN-훾+ IL-2+ TNF-훼+” CD4+ T-cell subsets
were observed in LTBI patients compared to active TB
patients (푃 = 0.003 and 푃 = 0.034, respectively; by Mann-
Whitney test) (Figure 3(a)). Conversely, the frequency of
other single- or double-cytokine-secreting CD4+ T cells did
not differ significantly between these two groups.
However, the cytokine profile (Figure 3(b)) revealed that
in LTBI patients the proportion of polyfunctional CD4+ T
cells producing the 3 cytokines simultaneously was greater
(23%) compared to other double-cytokine-producing CD4+
T cells (IFN-훾+ TNF-훼+ = 4%; IL-2+ TNF-훼+ = 4%; IFN-훾+
IL-2+ = 16%), but similar to single-cytokine-producing CD4+
T cells (TNF-훼+ = 27%, IFN-훾+ = 18%). In contrast, subjects
with active TB showed a smaller proportion of polyfunctional
CD4+ T cells (8%) and a predominance of CD4+ T-cell subset
secreting TNF-훼 alone which constituted 46% of the total
cytokine response.
Based on these differences, we performed a ROC analysis
(Figure 4(a)) and cut-off < 0.182% for polyfunctional CD4+
T cells allowed the best combination of sensitivity (77.78%,
95% CI: 52.36–93.59) and specificity (70%, 95% CI: 34.75–
93.33%; AUC 0.8444; 95% CI: 0.7021–0.9868%, 푃 = 0.0002)
to differentiate between active TB and LTBI subjects. Using
this cut-off to score ICCFC responses as either positive or
negative, we observed a positive response (>0.182%) in 4
out of 18 (22%) active TB patients and in 7 out of 10 (70%)
LTBI patients (Figure 4(b)). In our hands, the frequency of
polyfunctional CD4+ T cells which simultaneously produced
IFN-훾, IL-2, and TNF-훼may be indicative of LTBI status.
3.4. Specific CD8+ T-Cell Responses to Mtb Antigens in Intra-
cellular Cytokine Flow Cytometry. The analysis of activated
CD8+ T cells, producing any of the 3 cytokines (IFN-훾 or
IL-2 or TNF-훼) showed similar results to CD4+ T cells,
revealing a significant greater frequency of activated CD8+
T cells in both active TB (median 0.599%, range 0–4.55%)
and LTBI patients (0.489%, 0–1.796%) compared to healthy
controls (0%, range 0–0.249%, 푃 < 0.0020 by Kruskal-Wallis
test), but no difference was found between two groups of
infected individuals (Figure 5(a)). Likewise, the frequency
of “total IFN-훾+ CD8+ T cells” (Figure 5(b)), “total IL-2+
CD8+ T cells” (Figure 5(c)), and “total TNF-훼+ CD8+ T cells”
(Figure 5(d)) was significantly higher in active TB patients
compared to the other 2 groups of patients.These differences
were only statistically significant between active TB subjects
and healthy controls (푃 = 0.0045 for IFN-훾+; 푃 = 0.0033 for
IL-2; 푃 = 0.0078 for TNF-훼 by Kruskal-Wallis test).
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Figure 4: Differentiation between active and latent Mtb-infected subjects. (a) ROC curve (plotting sensitivity versus 1 − specificity) to
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Figure 5: Analysis of cytokine production by CD8+ T cells at the single-cell level. (a) Frequencies of activated Mtb-specific CD8+T cells
producing any of the 3 cytokines (IFN-훾, IL-2, or TNF-훼) cells in active TB patients (푛 = 18), in LTBI patients (푛 = 10), and in healthy
controls (푛 = 10) are show. ((b), (c), and (d)) Frequency of “total IFN-훾+,” “total IL-2+,” and “total TNF-훼+”Mtb-specific CD8+T in active TB
patients (푛 = 18), in LTBI patients (푛 = 10), and in healthy controls (푛 = 10) is shown. Horizontal bars represent themedian values. Statistical
analysis was performed using Kruskal-Wallis ANOVA with Dunn’s posttest comparison and significant differences are indicated by asterisks
(∗∗푃 < 0.01).
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Figure 6: Multifunctional cytokine analysis of Mtb-specific CD8+ T cells. (a) Frequency of Mtb-specific CD8+ T cells producing all
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of the panel (a).
As regards the cytokine profiles of Mtb-specific CD8+ T
cells, we found no significant differences between active TB
and LTBI subjects (푃 > 0.05 for each CD8+ T-cell subset
by Mann-Whitney test; Figure 6(a)). Still, observing the pie
charts (Figure 6(b)) the proportions of single-, double-, or
triple-cytokine-secreting CD8+ T-cell subsets were compara-
ble between two groups of individuals.
Hence, the evaluation of the Mtb-specific CD8+ T-cell
responses in both monofunctional and polyfunctional analy-
ses did not allow the distinction between active TB and LTBI
subjects.
4. Discussion
In recent years, immunological response to Mtb has been
extensively studiedwith the purpose of not only better under-
standing the TB pathogenesis but also improving diagnosis.
The more recent IGRA offer some improvements over the
TST, showing an excellent specificity for LTBI diagnosis and
correlating well with the magnitude of exposure toM. tuber-
culosis [21]. Nevertheless, they have several known limitations
including the reduced accuracy in immunocompromised
subjects [22–24], the presence of conversions and reversions
of results when serially applied in the same individuals [25–
27], the inability to distinguish reactivation from reinfection,
and the inability to accurately differentiate between LTBI and
active TB [5, 6].
In the present study, using IGRA assay as a tool for TB
detection, no significant differences in the average IFN-훾
responses were observed among our TB and LTBI subjects,
since similar percentages of positive IFN-훾 responses were
present in both of the 2 groups.
With a view to improving discrimination between active
TB and LTBI, we applied an intracellular cytokine flow
cytometry (ICCFC) to investigate monofunctional and mul-
tifunctionalMtb-specific CD4+ and CD8+ T cells.
Multifunctional T cells simultaneously secreting IFN-훾,
TNF-훼, and IL-2 play a critical role in the control of chronic
bacterial and viral infections [28]. Changes in cytokine
profiles could be a general feature of Mtb-specific T cells in
TB infection, but limited and controversial data have made
it difficult to define the role of these cells in TB [29]. Some
studies support the concept that a higher proportion of triple-
positive CD4+ T cells correlates with LTBI when comparing
active TB and latent subjects, suggesting that this T-cell subset
may be a surrogate marker of Mtb load and consequently
of active replication control in LTBI subjects [10, 15, 17]. In
contrast, others indicate a higher proportion of triple-positive
CD4+ T cells in active TB than in LTBI subjects [7, 9], but the
methodology used was different and so was the definition of
LTBI.
The present study provides a detailed analysis of the
frequency of cytokine-producing CD4+ and CD8+ T cells in
Mtb-infected (active TB and LTBI) and uninfected subjects.
Regarding the CD4+ T-cell compartment, the first finding
was that analysis of activated cells producing any of the 3
cytokines (IFN-훾 or IL-2 or TNF-훼) may help to differentiate
Mtb-infected (active TB and LTBI) and uninfected subjects.
In fact with a cut-off > 0.45% for activated CD4+ T cells,
we scored as positive the 95% of active TB patients, the 90%
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Figure 7: Proposed immune-based model for detection of active and latent TB. Taking into account the analysis of activated CD4+ T cells,
it is possible to differentiateMtb-infected subjects (>0.45%) by uninfected subjects (<0.45%). With the analysis of multifunctional CD4+ T
cells, simultaneously producing all 3 cytokines, infected individuals may be classified as active TB subjects (<0.182%) or as LTBI subjects
(>0.182%).
of LTBI patients, and none of healthy controls, clearly
differentiating Mtb-infected patients from healthy controls.
It is interesting to note that active TB patients showed
a low response using TST and QFT (only 61% and 72%,
resp.) confirming that routinely immunological tests were not
useful in diagnosis of active disease. Our data suggest that
analysis of activated CD4+ T cells has a good sensitivity in
active TB.
Also the analysis of CD4+ T cells secreting IFN-훾 alone,
IL-2 alone, and TNF-훼 alone, revealed a prevalent frequency
of all these T cells in infected compared to uninfected
subjects. Still, it is interesting to note a slightly higher
frequency of both “all IFN-훾+” and “all IL-2+” CD4+ T cells in
LTBI patients with respect to active TB patients, in line with
recent studies showing that CD4+ T cells producing IFN-훾
and IL-2 have been implicated in protective immunity to TB
[30, 31]. Taken together, monofunctional analysis was able to
distinguish infected and uninfected subjects but was unable
to indicate TB status not allowing a clear distinction between
active and latent infection.
Moreover searching for a difference between active and
latent TB, we performed a broad characterization of the
functional profiles ofMtb-specific CD4+ T cells to determine
all combinations of intracellular expression of IFN-훾, IL-
2, and TNF-훼. These findings revealed that latent infection
is associated with an increased frequency of two CD4+
T-cell subsets, those producing IFN-훾, IL-2, and TNF-훼
simultaneously (triple-positive) and those producing IFN-훾
in combination with TNF-훼, indicating a possible protective
role of these cells population in maintaining latent inflec-
tion. Indeed, we found that multifunctional CD4+ T cells,
in particular those producing 3 cytokines simultaneously,
provided the best discrimination between active and latent
infection. In fact using a cut-off of 0.182% for triple-positive
CD4+ T cells, most LTBI subjects (70%) showed a positive
response, whereas the majority of active TB patients (78%)
have a response below the cut-off.
Taken together, the detection of less than 0.182%of triple-
positive CD4+ T cells is strongly indicative of active TB with
a specificity of 70%, whereas frequencies of these cells above
0.182% could be indicative of LTBI with sensitivity of 77.7%.
Most notably and in contrast with latent infection, our
subjects with active TB disease had a predominance of CD4+
T cells secreting TNF alone which constituted 46% of the
total cytokine response. This is in agreement with previous
studies showing that TNF production is a major component
of the immune response to Mtb-antigen in active disease
and thus the most reliable marker for diagnosing TB disease
[7, 10, 11, 32, 33]. TNF expansion could be responsible for a
high degree of inflammation, which could be linked to tissue
damage and lung lesions rather than protection and control
of the pathogen.
According to what has been assumed to be the hallmark
of a protective CD4+ T-cell response in various models of
human viral infections [28, 34, 35], we found a significantly
higher proportion of multifunctional IFN-훾+ IL-2+ TNF-훼+
CD4+ T cells in subjects with LTBI, which are able to control
Mtb replication comparedwith thosewith current TBdisease,
in which CD4+ T cells secreting TNF alone dominated the
Mtb-specific response.
As regards the CD8+ T-cell compartment, Rozot et al.
[36, 37] recently indicated that Mtb-specific CD8+ T-
cell responses can be detected predominantly in patients
with active TB as compared to LTBI subjects, suggesting
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a correlation between CD8+ T-cell responses and high anti-
gen burden [19, 38].This hypothesis is supported by a recent
study performed in children showing thatMtb-specific CD8+
T cells were detected in active TB disease but not in healthy
children recently exposed toMtb, despite the fact that similar
frequencies of CD4+ T cells were present in both groups [39].
Moreover, little is known about the size, quality, and
specificity of Mtb-specific CD8+ T-cell responses during
active and latent infection. In our study, the monofunc-
tional analysis allowed a distinction between infected and
uninfected subjects, following the same trend as in CD4+ T
cells. Conversely, the polyfunctional analysis of CD8+ T-cell
responses showed no significant differences between active
and latent infected patients.
The present study has some limitations, such as the
relatively small number of patients within each clinical group
and the lack of a prospective analysis. Nevertheless, the
ICCFC assessment of multifunctional Mob-specific CD4+ T
cells enabled us to determine the different clinical stage of
TB infection. In this respect we propose an immune model
(Figure 7) which, with a cut-off of 0.45% for activatedCD4+ T
cells, may initially discriminateMtb-infected (active TB and
LTBI) patients (>0.45%) from uninfected subjects (<0.45%)
with a specificity of 100%.Then, the infected individuals may
be classified as active TB subjects if they showed frequencies
of triple-positive T cells less than 0.182% and as LTBI subjects
if the frequencies of triple-positive T cells are instead above
0.182% with a sensitivity of 77.78% and a specificity of 70%.
5. Conclusion
Multifunctional flow cytometry analysis of specific CD4+ T-
cell response may represent a simple and rapid immune-
based approach to distinguish between Mtb-infected and
uninfected subjects. The more interesting result of the study
is the increased number of active TB patients detected
with multifunctional analysis of CD4+ T-cell response in
comparison to QTF-GIT or TST. As general use as a clinical
diagnostic test in order to identify patients with active versus
latent TB infection, this immunological approach needs to be
validated in a larger and prospective study and to be extended
to other forms of active tuberculosis.
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